Expertise in
24
conditions

Dr. Michael C. Trendle

Hematology | Oncology
Curators Of The University Of Missouri
1 Hospital Dr, 
Columbia, MO 
Accepting New Patients
Expertise in
24
conditions
Curators Of The University Of Missouri
1 Hospital Dr, 
Columbia, MO 

Overview

Michael Trendle is a Hematologist and an Oncologist practicing medicine in Columbia, Missouri.

Dr. Trendle is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, Colorectal Cancer, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 2 clinical trials. Dr. Trendle is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in MO

Hospital Affiliations

Bothwell Regional Health Center
University Of Missouri Health Care

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MercyCare
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Curators of the University of Missouri
1 Hospital Dr, Columbia, MO 65212

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
Enrollment Status: Completed
Publish Date: September 20, 2021
Intervention Type: Radiation, Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

2 Total Publications

Guideline-compliant adjuvant chemotherapy for resected high risk oral cavity cancer: Homefield advantage.
Guideline-compliant adjuvant chemotherapy for resected high risk oral cavity cancer: Homefield advantage.
Journal: American journal of otolaryngology
Published: July 16, 2023
Similar Doctors
Expertise in
84
conditions
Dr. Umasankar Ramadoss
Hematology | Oncology
Expertise in
84
conditions
Dr. Umasankar Ramadoss
Hematology | Oncology
Referral may be required

Boone Hospital Center

1600 E Broadway, 
Columbia, MO 
 (1.0 miles away)
573-815-8000
Languages Spoken:
English
See accepted insurances

Umasankar Ramadoss is a Hematologist and an Oncologist practicing medicine in Columbia, Missouri. Dr. Ramadoss is highly rated in 84 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, Bone Marrow Aspiration, and Liver Embolization.

Expertise in
42
conditions
Dr. Tamara V. Hopkins
Hematology | Oncology
Expertise in
42
conditions
Dr. Tamara V. Hopkins
Hematology | Oncology
Referral may be required
1241 W. Stadium Blvd., 
Jefferson City, MO 
 (26.3 miles away)
573-635-5264
Languages Spoken:
English
See accepted insurances

Tamara Hopkins is a Hematologist and an Oncologist practicing medicine in Jefferson City, Missouri. Dr. Hopkins is highly rated in 42 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Endoscopy, and Bone Graft. Dr. Hopkins is board certified in Missouri Dept Of Health/Narcotics&Dangerous Drugs , Missouri State Board Of Registration, American Board Of Internal Medicine/Medical Oncology , and Drug Enforcement Administration .

Expertise in
7
conditions
Dr. Puja Nistala
Hematology | Oncology
Expertise in
7
conditions
Dr. Puja Nistala
Hematology | Oncology
Referral may be required

The Curators Of The University Of Missouri

1 Hospital Dr, 
Columbia, MO 
 (0.1 miles away)
573-882-4141
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Puja Nistala is a Hematologist and an Oncologist practicing medicine in Columbia, Missouri. Dr. Nistala is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Nistala is board certified in American Board Of Internal Medicine/Medical Oncology and American Board Of Internal Medicine/Hematology. Dr. Nistala is currently accepting new patients.

Frequently Asked Questions about Dr. Michael C. Trendle

How do I make an appointment with Dr. Michael C. Trendle?

You can book an appointment with Dr. Michael C. Trendle by calling their office at 573-882-8445. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael C. Trendle a top-rated expert for Small Cell Lung Cancer (SCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael C. Trendle is classified as an Distinguished expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael C. Trendle specialize in?

While Dr. Michael C. Trendle is a Hematology, they have specific expertise in Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Michael C. Trendle participate in research or clinical trials?

Yes. Dr. Michael C. Trendle has published 2 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Dr. Michael C. Trendle's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael C. Trendle accept my insurance?

Dr. Michael C. Trendle accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 573-882-8445 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Trendle's expertise for a condition
ConditionClose
    View All 20 Advanced Conditions
    View All 132 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile